Pharmacology, Toxicology and Pharmaceutics
| ISSN | 0169409X, 18728294 |
|---|---|
| Country | Netherlands |
| Publisher | Elsevier BV |
| Subject Areas | Pharmacology, Toxicology and Pharmaceutics |
| Publication Type | Journals |
| Active Years | 1987-ongoing |
| Competitiveness | *Invite-based |
| Publication Time | 2. Quick (1-3 months) |
| Website | Visit journal |
| JIF 2022–2023 | 15.200 |
| 2019-2020 SCR Rank | 199 |
| 2020-2021 SCR Rank | 219 |
The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery. In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues.
| Year | 2-Year IF | 3-Year IF | 4-Year IF |
|---|---|---|---|
| 2022 | 15.829 | 16.663 | 17.458 |
| 2021 | 16.040 | 17.099 | 17.547 |
| 2020 | 13.267 | 14.384 | 17.273 |
| 2019 | 12.212 | 15.877 | 15.188 |
| 2018 | 14.974 | 14.268 | 14.442 |
| 2017 | 12.957 | 13.563 | 15.768 |
| 2016 | 11.441 | 15.175 | 16.945 |
| 2015 | 15.725 | 17.227 | 18.077 |
| 2014 | 15.563 | — | — |
| 2013 | 13.378 | — | — |
| 2012 | 13.465 | — | — |
| 2011 | 11.718 | — | — |
| 2010 | 13.763 | — | — |
| 2009 | 12.163 | — | — |
| 2008 | 8.237 | — | — |
| 2007 | 7.825 | — | — |
| 2006 | 8.436 | — | — |
| 2005 | 7.550 | — | — |
| 2004 | 7.839 | — | — |
| 2003 | 6.532 | — | — |
| 2002 | 4.435 | — | — |
| 2001 | 3.120 | — | — |
| 2000 | 2.298 | — | — |
Note: impact factor data for reference only.
SJR measures scientific influence, weighting citations by the prestige of the citing journal.
| Year | SJR Score |
|---|---|
| 2023 | 3.411 |
| 2022 | 2.982 |
| 2021 | 2.934 |
| 2020 | 3.475 |
| 2019 | 4.082 |
| 2018 | 4.163 |
| 2017 | 4.090 |
| 2016 | 4.262 |
| 2015 | 5.054 |
The H-Index measures both the productivity and citation impact of a journal's publications.
| Year | H-Index |
|---|---|
| 2023 | 366.000 |
| 2022 | 348.000 |
| 2021 | 331.000 |
| 2020 | 313.000 |
https://www.elsevier.com/journals/advanced-drug-delivery-reviews/0169-409x/guide-for-authors